Gilead Sciences Chairman & CEO Daniel O'Day Reports Routine RSU Vesting and Tax Withholding
GILEAD SCIENCES, INC.
Subscribe to track GILD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 4 Alert: Gilead Sciences, Inc. ($GILD) Insider: Daniel Patrick O'Day (Chairman & CEO) Transaction: Tax Withholding (Code F) following RSU Vesting Shares Withheld: 4,230 shares @ $144.81 ($612,546.30) Shares Acquired: 8,780 shares (RSU conversion) Shares Retained Post-Transaction: 581,683 (Direct) Significance: Low (Standard equity compensation vesting and mandatory tax settlement)
Comprehensive Analysis
Executive Summary
On September 11, 2026, Gilead Sciences, Inc. ($GILD) filed a Form 4 on behalf of Chairman & CEO Daniel Patrick O'Day. The filing reflects the scheduled vesting of 8,780 Restricted Stock Units (RSUs) and the automatic withholding of 4,230 shares of common stock at $144.81 per share ($612,546.30 total value) to satisfy applicable tax liabilities.
Transaction Breakdown
- Security: Common Stock
- Vesting / Acquisition (Code M): 8,780 shares acquired upon RSU settlement.
- Tax Withholding (Code F): 4,230 shares disposed of at $144.81 per share.
- Net Share Increase: +4,550 common shares.
- Post-Transaction Direct Holdings: 581,683 common shares.
- Remaining RSUs: 83,300 units.
Market & Governance Impact
This transaction is routine and executed pursuant to standard executive equity compensation vesting schedules and tax withholding provisions. It does not represent open-market discretionary selling or buying by the CEO, resulting in a Low market significance rating.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.